Reduced promoter methylation and increased expression of CSPG4 negatively influences survival of HNSCC patients.
Warta R, Herold-Mende C, Chaisaingmongkol J, Popanda O, Mock A, Mogler C, Osswald F, Herpel E, Küstner S, Eckstein V, Plass C, Plinkert P, Schmezer P, Dyckhoff G.
Warta R, et al. Among authors: dyckhoff g.
Int J Cancer. 2014 Dec 1;135(11):2727-34. doi: 10.1002/ijc.28906. Epub 2014 Apr 26.
Int J Cancer. 2014.
PMID: 24740185